Amjevita represents the first biosimilar to the blockbuster drug Humira, kicking off what will likely be a firestorm of clones.

Source: https://investorplace.com/2023/01/amgen-layoffs-2023-what-to-know-about-the-latest-amgn-job-cuts/

It is another good step in the important out-licensing biosimilar business.

Source: https://seekingalpha.com/article/4647849-fresenius-se-and-co-kgaa-fsnuf-q2-2023-earnings-call-transcript?source=feed_all_articles

Management also expects to this year a biosimilar for arthritis treatment, Humira, pending U.S. regulatory approval, to boost revenue.

Source: https://seekingalpha.com/article/4596555-teva-pharmaceutical-stock-stabilizing-hinting-payoff-potential?source=feed_all_articles

Naturally, if there is a more effective and safe drug than Humira available for the same indication, then physicians are likely to prescribe it over Humira, or a Humira biosimilar.

Source: https://seekingalpha.com/article/4570975-abbvie-modelling-post-humira-bull-case-2030-bright-outlook?source=feed_all_articles

No, the principal risk that could knock Exelixis back is its biosimilar competition.

Source: https://seekingalpha.com/article/4570748-exelixis-stock-near-term-cautious-buy?source=feed_all_articles

P.E.I.'s move to biosimilar drugs will save money — but is there a cost?

Source: https://www.cbc.ca/news/canada/prince-edward-island/pei-health-biologic-medications-switch-1.7003457?cmp=rss

The enhanced global availability of more biosimilar products will undoubtedly benefit patients, health systems, and our partners in the regions.

Source: https://seekingalpha.com/article/4647849-fresenius-se-and-co-kgaa-fsnuf-q2-2023-earnings-call-transcript?source=feed_all_articles